Elanco Animal Health Incorporated (ELAN)

29.41 +0.01 (+0.03%) As of 2:54PM EDT. Market open.

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
http://www.elanco.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 10,200

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jeffrey N. Simmons	Pres, CEO & Director	2.1M	N/A	1967
Mr. Todd S. Young	Exec. VP of Corp. Governance and Strategy & CFO	934.92k	N/A	1972
Mr. Aaron L. Schacht	Exec. VP of Innovation, Regulatory & Bus. Devel.	955.32k	N/A	1968
Mr. James M. Meer	VP & Chief Accounting Officer	N/A	N/A	1970
Mr. Chris Keeley	Sr. VP & Chief Information Officer	N/A	N/A	N/A
Mr. David S. Kinard	Exec. VP of HR Corp. Affairs & Admin.	N/A	N/A	1967
Ms. Tiffany Ann Kanaga	Head of Investor Relations	N/A	N/A	N/A
Ms. Racquel Harris Mason	Exec. VP & Chief Marketing Officer	N/A	N/A	1970
Mr. Ramiro Martin Cabral	Exec. VP of Elanco International	N/A	N/A	1972
Mr. David Alan Urbanek	Exec. VP of Manufacturing & Quality	N/A	N/A	1967

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Corporate governance

Elanco Animal Health Incorporated’s ISS governance QualityScore as of 1 April 2021 is 7. The pillar scores are Audit: 5; Board: 8; Shareholder rights: 9; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.